日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Generation and preclinical characterization of a novel bispecific CD19-TCRgammadelta antibody for the treatment of B cell acute lymphoblastic leukemia

用于治疗B细胞急性淋巴细胞白血病的新型双特异性CD19-TCRγδ抗体的制备和临床前表征

Kauer, Joseph; Vogt, Fabian; Hörner, Sebastian; Schmidt, Valentin; Müller-Tidow, Carsten; Raffel, Simon; Salih, Helmut R; Jung, Gundram; Pflügler, Martin

Characterization of TROP-2 bispecific T cell engagers for immunotherapy of triple negative breast and bladder cancer

TROP-2双特异性T细胞衔接器在三阴性乳腺癌和膀胱癌免疫治疗中的应用特性分析

Ávila-Nieto, Carlos; Jung, Gundram; Salih, Helmut R; Hagelstein, Ilona

CLEC12A-directed immunocytokine with target cell-restricted IL-15 activity for treatment of acute myeloid leukemia

靶向CLEC12A的免疫细胞因子,具有靶细胞限制性IL-15活性,用于治疗急性髓系白血病

Klimovich, Boris; Anton, Leonard; Jung, Jinwon; Lim, Yangmi; Lee, Bora; Won, Jonghwa; Zekri, Latifa; Chashchina, Anna; Pflügler, Martin; Heitmann, Jonas S; Jung, Gundram; Salih, Helmut R

CD19-immunoPET for noninvasive visualization of CD19 expression in B-cell lymphoma patients

CD19免疫PET可用于无创可视化B细胞淋巴瘤患者CD19表达

Sonanini, Dominik; Schwenck, Johannes; Blaess, Simone; Schmitt, Julia; Maurer, Andreas; Ehrlichmann, Walter; Ritter, Malte; Skokowa, Julia; Kneilling, Manfred; Jung, Gundram; Fend, Falko; Krost, Simon; Seitz, Christian M; Lang, Peter; Reischl, Gerald; Handgretinger, Rupert; Fougère, Christian la; Pichler, Bernd J

Targeting CD276 for T cell-based immunotherapy of breast cancer

以 CD276 为靶点的乳腺癌 T 细胞免疫治疗

Ilona Hagelstein, Laura Wessling, Alexander Rochwarger, Latifa Zekri, Boris Klimovich, Christian M Tegeler, Gundram Jung, Christian M Schürch, Helmut R Salih, Martina S Lutz

An Fc-modified monoclonal antibody as novel treatment option for pancreatic cancer

一种Fc修饰的单克隆抗体作为胰腺癌的新型治疗选择

Lutz, Martina S; Wang, Kevin; Jung, Gundram; Salih, Helmut R; Hagelstein, Ilona

Protocol of a first-in-human clinical trial to evaluate the safety, tolerability, and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal cancer (CoRe_CC-3)

首次人体临床试验方案,旨在评估双特异性 CD276xCD3 抗体 CC-3 在结直肠癌患者中的安全性、耐受性和初步疗效 (CoRe_CC-3)

Jung, Susanne; Schlenk, Richard F; Hackenbruch, Christopher; Roldan Pinzon, Sandra S L; Bitzer, Michael; Pflügler, Martin; Walz, Juliane S; Jung, Gundram; Heitmann, Jonas S; Salih, Helmut R

Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease

一项评估Fc优化FLT3抗体FLYSYN在伴有可测量残留病灶的急性髓系白血病患者中疗效的I期研究

Heitmann, Jonas S; Schlenk, Richard F; Dörfel, Daniela; Kayser, Sabine; Döhner, Konstanze; Heuser, Michael; Thol, Felicitas; Kapp-Schwoerer, Silke; Labrenz, Jannik; Edelmann, Dominic; Märklin, Melanie; Vogel, Wichard; Bethge, Wolfgang; Walz, Juliane S; Große-Hovest, Ludger; Steiner, Martin; Jung, Gundram; Salih, Helmut R

An optimized IgG-based B7-H3xCD3 bispecific antibody for treatment of gastrointestinal cancers

一种优化的基于 IgG 的 B7-H3xCD3 双特异性抗体,用于治疗胃肠道癌症

Latifa Zekri, Martina Lutz, Nisha Prakash, Timo Manz, Boris Klimovich, Stefanie Mueller, Sebastian Hoerner, Ilona Hagelstein, Monika Engel, Anna Chashchina, Martin Pfluegler, Jonas S Heitmann, Gundram Jung, Helmut R Salih

Novel ACE2 fusion protein with adapting activity against SARS-CoV-2 variants in vitro

一种新型ACE2融合蛋白在体外对SARS-CoV-2变异株具有适应性活性。

Zekri, Latifa; Ruetalo, Natalia; Christie, Mary; Walker, Carolin; Manz, Timo; Rammensee, Hans-Georg; Salih, Helmut R; Schindler, Michael; Jung, Gundram